Literature DB >> 14688332

T cell clonal conditioning: a phase occurring early after antigen presentation but before clonal expansion is impacted by Toll-like receptor stimulation.

Joseph R Maxwell1, Robert J Rossi, Stephen J McSorley, Anthony T Vella.   

Abstract

After in vivo immunization, Ag-specific T cells disappear from circulation and become sequestered in lymphoid tissue where they encounter Ag presented by dendritic cells. In the same site and just after Ag presentation, they "disappear" a second time and we investigated this process. Using a mouse model of T cell deletion (without Toll-like receptor (TLR) stimulation) vs survival (with TLR stimulation), Ag-specific T cells indeed became undetectable by flow cytometry, however were readily detected by immunohistochemistry. Thus, whether or not the activated T cells were destined to delete or survive, they were difficult to extract from lymphoid tissue and did not disappear but in fact were abundantly present. Nevertheless, profound differences were observed during this time period when tolerizing conditions were compared with immunizing conditions. TLR stimulation induced an increase in CD25 expression, acquisition of surface MHC class II, and abnormally high increases in forward and side scatter of the peptide-specific T cells. Using a modified adoptive transfer approach, we demonstrated by flow cytometry that in the presence of TLR stimulation the Ag-specific T cells were tightly coupled to dendritic cells, explaining the unusual increases in size and granularity. Ultimately, these events induced the specific T cells to differentiate into memory cells. We postulate that this is a stage where T cells are either conditioned to survive or to delete depending upon the activation status of the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688332     DOI: 10.4049/jimmunol.172.1.248

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  T cell and APC dynamics in situ control the outcome of vaccination.

Authors:  Kamal M Khanna; David A Blair; Anthony T Vella; Stephen J McSorley; Sandip K Datta; Leo Lefrançois
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response.

Authors:  Meixiao Long; Adam J Adler
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages.

Authors:  Ingo Klein; Judith C Cornejo; Noelle K Polakos; Beena John; Sherry A Wuensch; David J Topham; Robert H Pierce; Ian Nicholas Crispe
Journal:  Blood       Date:  2007-08-09       Impact factor: 22.113

4.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

5.  Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

Authors:  Paurvi Shinde; Wenhai Liu; Antoine Ménoret; Andrew D Luster; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2017-04-21       Impact factor: 4.962

6.  Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors.

Authors:  Hulin Wu; Arun Kumar; Hongyu Miao; Jeanne Holden-Wiltse; Timothy R Mosmann; Alexandra M Livingstone; Gabrielle T Belz; Alan S Perelson; Martin S Zand; David J Topham
Journal:  J Immunol       Date:  2011-09-23       Impact factor: 5.422

7.  A role for IFNgamma in differential superantigen stimulation of conventional versus plasmacytoid DCs.

Authors:  Guruprasaadh Muralimohan; Anthony T Vella
Journal:  Cell Immunol       Date:  2006-10-11       Impact factor: 4.868

8.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

9.  Attenuated T cell responses to a high-potency ligand in vivo.

Authors:  Emily Corse; Rachel A Gottschalk; Michelle Krogsgaard; James P Allison
Journal:  PLoS Biol       Date:  2010-09-14       Impact factor: 8.029

10.  Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF.

Authors:  Jeremy P McAleer; Robert J Rossi; Anthony T Vella
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.